However, this real-world single-center analysis is the first study to our knowledge that evaluates the longitudinal development of irAE in anti-PD-1 treated melanoma patients and their relationship to response and survival outcomes along with other demographic determinants of response and autoimmunity including age, gender and BMI. Here, PDCD1 is linked to Autoimmunity.